Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
CARDIOLOGY / RESEARCH LETTER
Mendelian randomization studies of diagnostic value of standard biochemistry serum enzymes portfolio in cardiovascular diseases
1
Department of Biochemistry and Molecular Biology, Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Medical University, China
Submission date: 2024-12-13
Final revision date: 2025-03-09
Acceptance date: 2025-03-28
Publication date: 2025-04-23
Corresponding author
Bin Zheng
Department of Biochemistry and Molecular Biology, Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Medical University, China
Department of Biochemistry and Molecular Biology, Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Medical University, China
Arch Med Sci 2025;21(2):695-700
TOPICS
REFERENCES (19)
1.
Vaduganathan M, Mensah GA, Turco JV, et al. The Global Burden of Cardiovascular Diseases and Risk: a compass for future health. J Am Coll Cardiol 2022; 80: 2361-71.
2.
Banach M, Kaźmierczak J, Mitkowski P, et al. Which patients at risk of cardiovascular disease might benefit the most from inclisiran? Polish experts’ opinion. The compromise between EBM and possibilities in healthcare. Arch Med Sci 2022; 18: 569-76.
3.
Bruckert E, Giral P, Fau-Ratziu V, et al. A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients. Metabolism 2002; 51: 1071-6.
4.
Kunutsor SK, Apekey Ta, Seddoh D, Walley J. Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis. Int J Epidemiol 2014; 43: 187-201.
5.
Kunutsor SK, Apekey TA, Khan H. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies. Atherosclerosis 2014; 236: 7-17.
6.
Wannamethee SG, Sattar N, Papcosta O, Lennon L, Whincup PH. Alkaline phosphatase, serum phosphate, and incident cardiovascular disease and total mortality in older men. Arterioscler Thromb Vasc Biol 2013; 33: 1070-76.
7.
Zhu W, Ma Y, Guo W, et al. Serum level of lactate dehydrogenase is associated with cardiovascular disease risk as determined by the framingham risk score and arterial stiffness in a health-examined population in China. Int J Gen Med 2022; 15: 11-7.
8.
Watanabe M, Okamura T, Kokubo Y, et al. Elevated serum creatine kinase predicts first-ever myocardial infarction: a 12-year population-based cohort study in Japan, the Suita study. Int J Epidemiol 2009; 38: 1571-9.
9.
Ghosh SS, Wang J, Yannie PJ, et al. Over-expression of intestinal alkaline phosphatase attenuates atherosclerosis. Circ Res 2021; 128: 1646-59.
10.
Goettsch C, Strzelecka-Kiliszek A, Bessueille L, et al. TNAP as a therapeutic target for cardiovascular calcification: a discussion of its pleiotropic functions in the body. Cardiovasc Res 2022; 118: 84-96.
11.
Hernández-Mosqueira C, Velez-Delvalle C, Kuri-Harcuch W. Tissue alkaline phosphatase is involved in lipid metabolism and gene expression and secretion of adipokines in adipocytes. Biochim Biophys Acta 2015; 1850: 2485-96.
12.
Paolicchi A, Emdin M, Ghliozeni E, et al. Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation 2006; 113: e844-5.
13.
Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 2005; 1129: 2078-80.
14.
Yamada J, Tomiyama H, Yambe M, et al. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis 2006; 189: 198-205.
15.
Swanson KV, Deng M, Ting JPY. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol 2019; 19: 477-89.
16.
Kazak L, Cohen P. Creatine metabolism: energy homeostasis, immunity and cancer biology. Nat Rev Mol Cell Biol 2020; 16: 421-36.
17.
Brewster LM, Haan YC, Zwinderman AH, et al. CK (creatine kinase) is associated with cardiovascular hemodynamics: the HELIUS study. Hypertension 2020; 76: 373-80.
18.
Schindhelm RK, Diamant M, Dekker JM, et al. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 2006; 22: 437-43.
19.
Azpiazu D, Gonzalo S, Villa-Bellosta R. Tissue non-specific alkaline phosphatase and vascular calcification: a potential therapeutic target. Curr Cardiol Rev 2019; 15: 91-5.
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
